DNA Extraction, Isolation, Purification Market Worth $6.10 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 04, 2023 09:25 ET
|
The Insight Partners
Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The method through which the DNA is purified is DNA extraction, by using physical and/or chemical methods from proteins, cell membranes, and other...
Poultry Diagnostics Market worth $792.70 Million by 2030 - Exclusive Report by The Insight Partners
September 22, 2023 09:06 ET
|
The Insight Partners
Pune, India, Sept. 22, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Poultry Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth...
Achiko AG Production and Sales Update
December 21, 2022 07:42 ET
|
Achiko AG
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests.Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match...
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders Adopt All Proposals
December 20, 2022 15:03 ET
|
Achiko AG
ZURICH, Switzerland, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) held its Annual General Meeting today at 10:00 CET in Zurich....
Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test
December 06, 2022 07:03 ET
|
Lucira Health Inc.
Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and...
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
November 17, 2022 07:03 ET
|
Lucira Health Inc.
Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira...
Achiko AG Announces Corporate Update Webcast
November 16, 2022 10:38 ET
|
Achiko AG
ZURICH, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare technology company that is developing new...
Achiko AG Commences Commercial Deliveries in Indonesia
November 14, 2022 07:30 ET
|
Achiko AG
ZURICH, Switzerland, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud to...
Achiko AG Production and Company Update
November 02, 2022 07:34 ET
|
Achiko AG
Completing Production Pilot for Generation 2 of AptameX™ as a Precursor to Mass Commercial ProductionExpect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of...
Achiko AG Appoints New Chief Financial Officer
October 07, 2022 07:30 ET
|
Achiko AG
ZURICH, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), a healthcare...